CollPlant Biotechnologies (CLGN) Interest Expenses (2017 - 2025)

CollPlant Biotechnologies' Interest Expenses history runs 9 years deep, the most recent figure standing at $28.8 million for Q4 2025.

• Quarterly Interest Expenses rose 26.64% year-over-year to $28.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $28.8 million (up 26.64% YoY) and the FY2025 annual result came in at $28.8 million, up 26.64% from the prior year.
• Interest Expenses was $28.8 million for Q4 2025 at CollPlant Biotechnologies, up from $22.8 million in the prior quarter.
• Across five years, Interest Expenses topped out at $35.0 million in Q4 2021 and bottomed at -$8.0 million in Q3 2021.
• A 5-year average of $15.0 million and a median of $20.9 million in 2022 frame the typical range for Interest Expenses.
• Peak annual rise in Interest Expenses reached 336.33% in 2021, while the deepest fall reached 375.0% in 2021.
• CollPlant Biotechnologies' Interest Expenses stood at $35.0 million in 2021, then slumped by 35.82% to $22.5 million in 2022, then decreased by 14.24% to $19.3 million in 2023, then climbed by 18.17% to $22.8 million in 2024, then increased by 26.64% to $28.8 million in 2025.
• Business Quant data shows CLGN's Interest Expenses at $28.8 million in Q4 2025, $22.8 million in Q4 2024, and $19.3 million in Q4 2023.